ENT Biotech Solutions

Detroit, United States Founded: 2011 • Age: 15 yrs
A disposable, single-use tool that cuts, cauterizes and removes tissue during tonsil and adenoid surgery
Annual revenue - Latest available
Total funding $2.0M 2 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 8 Brand Intelligence

About ENT Biotech Solutions

ENT Biotech Solutions is a company based in Detroit (United States) founded in 2011. ENT Biotech Solutions has raised $2.04 million across 2 funding rounds from investors including Michigan Economic Development. ENT Biotech Solutions operates in a competitive market with competitors including Protip Medical, Chemo Mouthpiece, APrevent, OTT Medical and Surgimed, among others.

  • Headquarter Detroit, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $2.04 M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.1 M (USD), Series A

    Apr 25, 2016

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of ENT Biotech Solutions

ENT Biotech Solutions has successfully raised a total of $2.04M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.1 million completed in April 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in ENT Biotech Solutions

ENT Biotech Solutions has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Michigan Economic Development.

All
Institutional
Investor Description Founded Year Domain Location
Economic development in Michigan is advanced by the foundation.
Locked Locked Locked
Premium access

Investor details for ENT Biotech Solutions

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ENT Biotech Solutions

Investments
Premium access

Investment portfolio details for ENT Biotech Solutions

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - ENT Biotech Solutions

Premium access

Detailed financials for ENT Biotech Solutions

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Ent Biotech Solutions Comparisons

ENT Biotech Solutions Primary company
Description
A disposable, single-use tool that cuts, cauterizes and remo...
Location
Detroit, United States
Founded Year
2011
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for ENT Biotech Solutions

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of ENT Biotech Solutions

ENT Biotech Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Protip Medical, Chemo Mouthpiece, APrevent, OTT Medical and Surgimed, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Implantable devices for larynx surgery are developed to reduce complications.
Locked Locked Locked
Developer of a cryotherapy device to cool the entire oral cavity
Locked Locked Locked
-
Locked Locked Locked
Offers professional architectural services for homeowners and commercial developers worldwide.
Locked Locked Locked
Develops innovative technologies for vocal cord nerve monitoring.
Premium access

Detailed competitors of ENT Biotech Solutions

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ent Biotech Solutions

Premium access

Complete news archive for ENT Biotech Solutions

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ENT Biotech Solutions

ENT Biotech Solutions was founded in 2011 and raised its 1st funding round 3 years after it was founded.

ENT Biotech Solutions is headquartered in Detroit, United States. It is registered at Detroit, Michigan, United States.

ENT Biotech Solutions is a funded company, having raised a total of $2.04M across 2 funding rounds to date.

ENT Biotech Solutions was founded in 2011 in Detroit, United States, within the medical device sector. Focus is placed on developing Elasso, a disposable, single-use tool designed for tonsil and adenoid procedures. Tissue is cut, cauterized, and removed in a single step during surgeries. Operations center on advancing ENT surgical tools to support clinical efficiency in the United States.

ENT Biotech Solutions's top competitors include Chemo Mouthpiece, Protip Medical and APrevent.

ENT Biotech Solutions has 1 investor. Key investors include Michigan Economic Development.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available